0
No Tax Breaks for Radical Corporate Activism Act
3/12/2025, 4:48 AM
Summary of Bill HR 1208
If passed, this legislation would impact businesses that currently reimburse employees for these specific expenses. The bill would prevent these businesses from deducting these reimbursements as trade or business expenses on their taxes.
Supporters of the bill argue that it is important to prevent taxpayer dollars from being used to fund procedures or travel related to child gender transitions or abortions. They believe that these are personal expenses that should not be subsidized by businesses or taxpayers. Opponents of the bill argue that it unfairly targets and discriminates against individuals seeking these specific medical procedures. They argue that employees should have the right to access these services without fear of financial repercussions or discrimination from their employers. Overall, Bill 119 hr 1208 is a controversial piece of legislation that raises important questions about the intersection of personal medical decisions, employer responsibilities, and tax policy. It will be interesting to see how this bill progresses through Congress and what impact it may have if it becomes law.
Congressional Summary of HR 1208
No Tax Breaks for Radical Corporate Activism Act
This bill disallows a business expense tax deduction for reimbursements or other amounts paid by an employer to an employee for travel expenses to obtain an abortion or expenses for any gender transition procedure for a minor child (under 18 years old) of an employee. (Under current law, a tax deduction generally is allowed for costs of operating a trade or business, subject to certain conditions and exceptions.)
The bill defines gender transition procedure as any medical or surgical service (including physician services, hospital services, and prescription drugs) that seeks to (1) alter or remove physiological or anatomical characteristics or features that are typical for the individual's biological sex, or (2) instill or create physiological or anatomical characteristics that resemble a sex different from the individual's sex at birth.
However, under the bill, the term gender transition procedure does not include services for treatment of a medically verified sex development disorder (e.g., the presence of 46 XX chromosomes with virilization, 46 XY chromosomes with undervirilization, or both ovarian and testicular tissue) or for the treatment of any infection, injury, disease, or disorder caused or exacerbated by the performance of any gender transition procedure.
